CIPO Patents = 1

EPO Patents = 4

Trademarks = 1

Forward Citations = 15

Loading Chart...

3 inventors (with patents filed for the assignee):

Thomas Sciascia (6 out of 13 patents)

Amale Hawi (1 out of 1 patent)

Shashank Rohatagi (1 out of 1 patent)

4. Jennifer Good (0 patent)

7 patents: Sort by Forward Citations

1. 12274696 - Methods of administering nalbuphine (2025-04-14),

2. 11660296 - Treatment of chronic cough, breathlessness and dyspnea (2023-05-30),

3. 10238646 - Methods for treating pruritus (2019-03-26),

4. 9624233 - Compounds for treating pruritic conditions (2017-04-18),

5. 8987289 - Methods for treating pruritus (2015-03-24),

6. 8940753 - Methods for treating pruritis (2015-01-27),

7. 8637538 - Methods for treatment of pruritis (2014-01-28),

Company Overview

Trevi Therapeutics is a clinical-stage biopharmaceutical company developing novel therapies for serious neurologically mediated conditions. The company's lead candidate, Nalbuphine ER, is being developed for the treatment of chronic pruritus, a severe itching condition. Trevi Therapeutics is dedicated to improving the lives of patients through innovative drug development.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

7 Patents

#29 in New Haven, CT

#818 in Connecticut

#39,879 in US

New Haven, CT, United States of America

Trevi Therapeutics Inc.

Forward Citations = 15

3 inventors:

Thomas Sciascia (6 out of 13 patents)

Amale Hawi (1 out of 1 patent)

Shashank Rohatagi (1 out of 1 patent)

4. Jennifer Good (0 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Trevi Therapeutics Inc.. Retrieved from https://idiyas.com/company/trevi-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

4 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]